Transplant Testing
HLA DSA Donor Specific IgG Antibodies Class I II Test
The HLA DSA Donor Specific IgG Antibodies Class I II Test helps assess compatibility for organ transplantation by detecting antibodies that could affect the success of the transplant. This test is important for patients undergoing transplantation, especially those with risk factors.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Blood or serum.
- Results
- Approximately 10-12 days. Confirm with the laboratory before booking.
- Preparation
- Confirm with the laboratory before booking. Sample should preferably be collected 48 hours after dialysis. A doctor's prescription on letterhead with a stamp is required, along with one photograph each of the recipient and donor.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the HLA DSA Donor Specific IgG Antibodies Class I II Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients undergoing organ transplantation.
- ✓Patients with a history of previous transplants.
- ✓Patients with known sensitization to HLA antigens.
- ✓Monitoring post-transplant patients for rejection risk.
- ✓Investigating unexplained organ dysfunction after transplant.
In plain language
What this test helps you understand
This test measures the presence of donor-specific IgG antibodies against Class I and Class II Human Leukocyte Antigens (HLA). Monitoring these antibodies is crucial for patients undergoing transplantation as their presence can indicate a heightened risk of transplant rejection.
Patients who have undergone previous transplants, those with a history of sensitization to HLA antigens, or individuals with certain medical conditions may be advised to take this test. It may also be considered if there is unexplained organ dysfunction after a transplant.
Taking this test offers several benefits, including early detection of potential transplant rejection risks, guidance for post-transplant care, and informed decision-making for patients and healthcare providers. Understanding your results is crucial for your healthcare journey. A positive result indicates the presence of donor-specific antibodies, which may require further evaluation and management by your transplant team. Regular monitoring may be necessary.
We have branches across major cities in Kenya and offer a home sample collection service. To book your test or for more information, please contact us.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Chimerism Split Cell Analysis T Cell CD3 Test
Monitors post-transplant recovery by measuring the proportion of donor and recipient T cells (CD3 positive) in the blood or bone marrow. Essential for assessing graft acceptance or rejection after hematopoietic stem cell transplantation.
Learn more →HLA ABC Class 1 Typing Test
The HLA ABC Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation.
Learn more →HLA AB Class 1 Typing Test
The HLA AB Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful kidney, liver, or heart transplants. This test identifies specific antigens to minimize organ rejection risk.
Learn more →HLA DP Typing Test
The HLA DP Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation. It assesses specific human leukocyte antigens (HLA) to minimize rejection risk.
Learn more →